INFU InfuSystem Holdings, Inc

NEUTRAL Impact: 2/10 8-K
Horizon immediate Filed May 12, 2026 Processed 11d 4h ago SEC 0001628280-26-034217
8-K context-dependent: Items 5.02
Latest settled — T+5d
INFU ▲ +17.78% at T+5d
NEUTRAL call ✓ call won +17.78% · α vs SPY +18.94% · entry $8.21 → $9.67
Next anchor: T+20d in 17d
Last close $9.66 (close May 22) · +17.66% from $8.21 entry
Entry anchored
May 12, 03:59 PM ET
via Databento tick
T+1d
0.00%
call 0.00% · α +0.00%
$8.21
settled 11d ago
T+5d
+17.78%
call +17.78% · α +18.94%
$9.67
settled 5d ago
T+20d
call — · α —
in 17d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

InfuSystem Holdings held its 2026 Annual Meeting on May 11, 2026, where all seven board nominees were elected, executive compensation was approved on a non-binding advisory basis, and stockholders approved a third amendment to the 2021 Equity Incentive Plan increasing the share reserve to 7,000,000 shares. This is a routine governance filing with no material financial impact.

Actionable Insight

This is a routine annual meeting filing with no material financial data or surprises. Monitor the next quarterly filing for any changes in share count or compensation expense related to the expanded equity plan.

Key Facts

  • All seven board nominees were elected at the 2026 Annual Meeting on May 11, 2026.
  • Stockholders approved the Third Amendment to the 2021 Equity Incentive Plan, increasing the maximum shares reserved for issuance to 7,000,000.
  • Stockholders ratified Grant Thornton LLP as the independent accounting firm for fiscal year 2026.
  • Executive compensation was approved on a non-binding advisory basis with 11,915,842 votes for and 1,071,346 against.
  • The Third Amendment was adopted by the Board on April 2, 2026 and approved by stockholders on May 11, 2026.

Financial Impact

No material financial impact. The equity plan amendment increases the share reserve to 7,000,000 shares, but no immediate dilution or financial effect is disclosed.

dilution

Risk Factors

  • Potential future dilution from equity awards under the expanded 7,000,000 share reserve.
  • No other material risks disclosed in this filing.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
91% bullish (11 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-034217
Document: infu20260511-exx101x2021eq.htm0001628280-26-034217
Document: 0001628280-26-034217-index-headers.html0001628280-26-034217
Document: 0001628280-26-034217-index.html0001628280-26-034217
Document: 0001628280-26-034217.txt0001628280-26-034217
7 reports for INFU
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for INFU — sortable, filterable
Type Now
May 18, 2026
5d ago
8-K
NEUTRAL ★ 4/10
$8.95 awaiting T+5awaiting T+5$9.66 (+7.93%)
May 14, 2026
9d ago
8-K
NEUTRAL ★ 2/10
$8.21 awaiting T+5awaiting T+5$9.66 (+17.66%)
May 12, 2026
11d ago
8-K
NEUTRAL ★ 2/10
$8.21 $9.67▲ +17.78%▲ +18.94%$9.66 (+17.66%)
May 8, 2026
16d ago
Insider Cluster
BULLISH ★ 5/10
$8.41 $8.61▲ +2.38%▲ +0.91%$9.66 (+14.86%)
May 8, 2026
16d ago
Insider Cluster
BULLISH ★ 5/10
$8.41 $8.61▲ +2.38%▲ +0.91%$9.66 (+14.86%)
May 7, 2026
16d ago
8-K
MIXED ★ 5/10
$8.97 $8.21▼ −8.47%▼ −9.98%$9.66 (+7.69%)
Apr 30, 2026
23d ago
8-K
NEUTRAL ★ 2/10
awaiting T+5
Showing 7 of 7

US Market Status

Market Closed — Opens Tue (35h 14m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access